LONG-TERM EVALUATION OF VASCULAR TOXICITY IN PATIENTS WITH PH+ LEUKEMIAS TREATED WITH BOSUTINIB

EHA Library, Kristen McGrory, 54240

CHROMOSOMAL ABNORMALITIES IN PHILADELPHIA CHROMOSOME (PH)-NEGATIVE METAPHASES IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE TREATED FRONTLINE WITH NILOTINIB OR DASATINIB

EHA Library, Shilpan Shah, 54241

CLINICAL EXPERIENCE OF BOSUTINIB UNDER COMPASIONATE USE PROGRAM IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH RESISTANCE OR INTOLERANCE TO IMATINIB, DASATINIB AND NILOTINIB

EHA Library, Valentin Garcia-Gutierrez, 54242

LONG-TERM ASSESSMENT OF CARDIAC TOXICITY IN PATIENTS WITH PH+ LEUKEMIAS TREATED WITH BOSUTINIB

EHA Library, Kristen McGrory, 54243

DESIGN OF RAPID FLUORESCENT MOLECULAR BEACON BASED PCR ASSAY FOR DETECTION AND QUANTIFICATION OF BCR –ABL TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Sunita Jetly, 54244

HYPOPHOSPHATEMIA AS A PREDICTOR OF RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML) TREATED WITH IMATINIB

EHA Library, Teresa Garrido, 54245

Risk and Impact of Tuberculosis in Patients with Chronic Myeloid Leukemia: A Nationwide Population-Based Study in Taiwan

EHA Library, Chia-Jen Liu, 54246

MULTICENTER CLINICAL STUDY TO EVALUATE A UTILITY OF FRET-BASED DRUG SENRITIVITY TEST THAT PREDICTS EARLY MOLECULAR RESPONSE IN NEWLY DIAGNOSED CML PATIENTS TREATED WITH NILOTINIB

EHA Library, Takeshi Kondo, 54247

FIRST PRELIMINARY REPORT OF ARAB LEUKEMIA NET (ALN) REGISTRY FOR CHRONIC MYELOID LEUKAEMIA (CML) IN THE MIDDLE EAST &NORTH AFRICA REGION.PART I EPIDEMIOLOGY OF CML IN EGYPT.

EHA Library, Mohamed Azzazi, 54248

UPDATED REPORT OF THE AUSTRIAN CML REGISTRY

EHA Library, Stefan Schmidt, 54249

10 YEARS' EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES

EHA Library, Dalia Khan, 54250

THE EFFECT OF DELAYED TKI TREATMENT ON CYTOGENETIC AND MOLECULAR RESPONSES IN CML PATIENTS: 8 YEAR FOLLOW-UP STUDY IN BOSNIA

EHA Library, Azra Kurtovic, 54253

BCR-ABL1 KINASE DOMAIN MUTATION ANALYSIS USING AMPLICON DEEP SEQUENCING ON THE ION TORRENT PLATFORM

EHA Library, Hui En Foong, 54255

THE INFLUENCE OF DISEASE AND COMORBIDITY RISK ASSESSMENTS ON THE SURVIVAL OF MDS PATIENTS TREATED WITH 5-AZACITIDINE

EHA Library, Alfredo Molteni, 54256

IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY

EHA Library, Pellegrino Musto, 54257

PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS

EHA Library, Joon Ho MOON, 54259

HIGHER BONE MARROW LGALS3 EXPRESSION PREDICTS FAVORABLE PROGNOSIS IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Hsin-An Hou, 54260

VALUE OF THE MULTIPARAMETRIC FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA UNDER HYPOMETHYLATING AGENT THERAPY.

EHA Library, Marcelo Iastrebner, 54261

CLINICAL VALUE OF MONOSOMAL KARYOTYPE AND COMPLEX KARYOTYPE AS PROGNOSTIC PARAMETER IN PATIENTS WITH IPSS INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

EHA Library, Moo-Kon Song, 54262

COEXPRESSION OF CD7 AND LINEAGE INFIDELITY MARKERS ON MYELOID PRECURSORS CORRELATES WITH RESPONSE TO AZACITIDINE IN IPSS HIGH RISK MDS PATIENTS

EHA Library, Elisa Cannizzo, 54263

IMPACT OF GRAFT-VERSUS-HOST DISEASE ON OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Jun Aoki, 54265

IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC TRASPLANT

EHA Library, María Díez Campelo, 54266

COMBINED ASSESSMENT OF WT1 AND BAALC EXPRESSION LEVELS IMPROVES RISK STRATIFICATION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Paola Minetto, 54268

IMPACT OF HIGH-DOSE RADIATION EXPOSURE ON NAGASAKI ATOMIC BOMB SURVIVORS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

EHA Library, Tatsuro Jo, 54269

TREG CELLS NUMBER FROM HIGH-RISK MYELODISPLASTIC SYNDROME PATIENTS IS INCREASE, BUT ITS SUPRESSION HABILITY IS IMPARED

EHA Library, Aline Perazzio, 54270

METHYLATION PATTERNS IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SINDROMES AND SECONDARY ACUTE MYELOID LEUKEMIA TREATED WITH HIPOMETHYLANT AGENTS (HIGH-RISK MDS 2009 PROTOCOL OF CETLAM GROUP).

EHA Library, Marta Cabezón, 54271

HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumour microenvironment

EHA Library, Enrica Borsi, 54272

PROTEASOME INHIBITORS MODULATE OSTEOCYTE DEATH AND AUTOPHAGY IN MULTIPLE MYELOMA.

EHA Library, Nicola Giuliani, 54276

THE METABOLIC STRESS INDUCED BY CYCLIN D1 IMPACTS CELL ADHESION, MIGRATION AND CELL ADHESION-MEDIATED DRUG RESISTANCE (CAM-DR) IN MYELOMA CELLS.

EHA Library, Sophie Bustany, 54277

CYCLIN D1 CONSTITUTIVE EXPRESSION SENSITIZES MULTIPLE MYELOMA CELLS TO BORTEZOMIB BY INHIBITING HEAT SHOCK PROTEINS.

EHA Library, Sophie Bustany, 54278

SERUM LEVELS OF DICKKOPF-1 PREDICT PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTAT BUT ITS PROGNOSTIC VALUE IS OVERCOME BY THE USE OF NOVEL DRUGS

EHA Library, Jiri Minarik, 54279

IMPACT OF EXONIZED ALUS ON SOLUBLE RANKL MRNA TRANSLATIONAL DYNAMICS.

EHA Library, Emmanouil Spanoudakis, 54280

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β- Catenin Signaling Pathway

EHA Library, Zhen Cai, 54281

PRECLINICAL ANTIMYELOMA ACTIVITY OF THE ALKYLATING-HDACI FUSION MOLECULE EDO-S101 THROUGH DNA-DAMAGING AND HDACI EFFECTS

EHA Library, Ana-Alicia López-Iglesias, 54282

CHARACTERIZATION OF SERUM AND GLUCOCORTICOID-INDUCIBLE KINASE 3 (SGK-3) AS A POTENTIAL ONCOGENIC ALTERNATIVE TO SIGNALLING VIA AKT IN MULTIPLE MYELOMA

EHA Library, Maria-Elisabeth Goebeler, 54285

IMMUNE IMPAIRMENTS IN MULTIPLE MYELOMA BONE-MARROW MESENCHYMAL STROMAL CELLS

EHA Library, Thibaud André, 54288

PREVALENCE AND PROGNOSIS SIGNIFICANCE OF THE MYD88 (L265P) MUTATION IN IgM MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Carlos Fernandez Delarrea, 54290

INHIBITION OF NAMPT AUGMENTS IBRUTINIB INDUCED KILLING IN MYD88 L265P EXPRESSING WALDENSTROM`S MACROGLOBULINEMIA CELLS.

EHA Library, Antonia Cagnetta, 54291

LONGITUDINAL COMPARISON OF PATIENTS\' AND PHYSICIANS\' PERCEPTIONS OF PATIENTS\' HEALTH-RELATED QUALITY OF LIFE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Hélène Gilet, 54294

TRANSIENT ELEVATION OF AST OR LDH AS AN EARLY PHARMACODYNAMIC BIOMARKER OF RECOMBINANT CIRCULARLY PERMUTED TRAIL (CPT) IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Wenming Chen, 54295

LONG TERM CRYOPRESERVED AUTOLOGOUS BLOOD STEM CELLS FOR SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN RELAPSED MULTIPLE MYELOMA PATIENTS

EHA Library, Nuchanan Areethamsirikul, 54296

MULTIPLE MYELOMA OF ELDERLY: COMORBIDITY INDEXES, SCALES, AND PERSONALIZED TREATMENT

EHA Library, Vladislava Djurasinovic, 54297

SMOULDERING MULTIPLE MYELOMA RISK FACTORS FOR PROGRESSION. AN ANALYSIS OF 289 CASES IN THE DANISH MULTIPLE MYELOMA REGISTRY

EHA Library, Rasmus Sørrig, 54298

THE UK AND IRELAND PERSPECTIVE: EUROPEAN POST-APPROVAL SAFETY STUDY (PASS) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE, BORTEZOMIB, AND THALIDOMIDE

EHA Library, Jenny Bird, 54299

IMPACT OF RENAL IMPAIRMENT ON THE EFFICACY AND SAFETY OF LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (RD) IN CHINESE PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): MM-021 TRIAL

EHA Library, Dao-Bin Zhou, 54300

SUPPRESSION OF THE NON-INVOLVED HLC PAIR CORRELATES WITH SURVIVAL IN NEWLY DIAGNOSED AND RELAPSED/REFRACTORY PATIENTS WITH MYELOMA

EHA Library, Heinz Ludwig, 54301

Phase 1 pharmacokinetic study of ixazomib plus lenalidomide and dexamethasone in East Asian patients with relapsed/refractory multiple myeloma

EHA Library, Neeraj Gupta, 54302

A COMBINATION THERAPY WITH BORTEZOMIB (BOR) AND THALIDOMIDE IN NEWLY DIAGNOSED MYELOMA PATIENTS IS ASSOCIATED WITH A LOW INCIDENCE OF SECOND PRIMARY MALIGNANCIES (SPMS)

EHA Library, Annamaria Brioli, 54304

DIFFERENT OUTCOMES AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION ACCORDING TO INVOLVED SITES IN MYELOMA PATIENTS WITH EXTRAMEDULLARY PLASMACYTOMA: BONE VERSUS SOFT TISSUE PLASMACYTOMA

EHA Library, Ho-Jin Shin, 54305

EARLY MORTALITY TREND IN MULTIPLE MYELOMA: A THIRTY-YEAR POPULATION-BASED STUDY

EHA Library, Rafael Rios-Tamayo, 54306

IMPACT OF PRIOR THERAPY (TX) ON THE EFFICACY AND SAFETY OF LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (RD) IN CHINESE PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): MM-021 TRIAL

EHA Library, Jie Jin, 54308

AN ONGOING OPEN-LABEL PHASE 1/2A STUDY OF THE SAFETY AND EFFICACY OF MELFLUFEN AND DEXAMETHASONE COMBINATION FOR PATIENTS WITH RELAPSED AND RELAPSED-REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Eva Nordström, 54309

A phase 1 study of the effect of a high-fat meal on the pharmacokinetics of ixazomib, an investigational oral proteasome inhibitor, in patients with advanced solid tumors or lymphoma

EHA Library, Neeraj Gupta, 54310

ROLE OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SYSTEMIC IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS: RESULTS IN A SERIES FROM A SINGLE INSTITUTION

EHA Library, Carlos Fernandez Delarrea, 54311

SAFETY PROFILE OF BORTEZOMIB IMPACTS SURVIVAL OF CARDIAC AL

EHA Library, Xavier Leleu, 54312

IMPACT OF INITIAL FGD-PET CT AND SERUM FREE LIGHT CHAIN ON TRANSFORMATION OF CONVENTIONALLY DEFINED SOLITARY PLASMACYTOMA TO MULTIPLE MYELOMA

EHA Library, Guillemette FOUQUET, 54313

NEGATIVE FLOW CYTOMETRY IS ASSOCIATED WITH A BETTER PROGRESSION-FREE SURVIVAL IN TREATED MULTIPLE MYELOMA PATIENTS: THE SINGLE-CENTER EXPERIENCE OF CHU DE CAEN IN A DAILY PRACTICE

EHA Library, Quentin Cabrera, 54314

HIGH INCIDENCE OF INTACT IMMUNOGLOBULIN OR FRAGMENTS THEREOF IN URINE OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maria Kraj, 54315

RELATIONSHIP BETWEEN CHROMOSOMAL ABERRATIONS AND CLINICAL OR LABORATORY VARIABLES IN MULTIPLE MYELOMA

EHA Library, Ewa Wawrzyniak, 54317

COST-EFFECTIVENESS IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (RD) VERSUS BORTEZOMIB PLUS MELPHALAN AND PREDNISONE (VMP)

EHA Library, James Cavenagh, 54318

SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH MONOCLONAL GAMMOPATHY: FRENCH EXPERIENCE OF THE CEREMAST

EHA Library, Talbot Alexis, 54319

MANAGEMENT OF RENAL IMPAIRMENT IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: PRELIMINARY DATA OF A LARGE OBSERVATIONAL, PROSPECTIVE STUDY

EHA Library, Antonio Garcia-Guiñon, 54320

ISOTYPE MATCHED IMMUNOGLOBULIN SUPPRESSION IN COMBINATION WITH CYTOGENETIC MARKERS PREDICTS OUTCOME IN MULTIPLE MYELOMA PATIENTS

EHA Library, Christian Langer, 54322

Autoimmune diseases during treatment with immunomodulatory drugs in Multiple Myeloma: selective occurrence after lenalidomide

EHA Library, Vittorio MONTEFUSCO, 54324

IMPACT OF NFKB1-94INS/DEL ATTG POLYMORPHISM ON DISEASE CHARACTERISTICS AND TREATMENT OUTCOME ON BORTEZOMIB BASED THERAPY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Gergely Varga, 54325

THIRD AUTOLOGOUS SALVAGE STEM CELL TRANSPLANT IN SUBJECTS WITH ADVANCED MULTIPLE MYELOMA

EHA Library, Susanne Strifler, 54326

TREATMENT WITH THE BILE-ACID SEQUESTRANT COLESEVELAM IMPROVES LENALIDOMIDE ASSOCIATED DIARRHOEA IN MYELOMA PATIENTS.

EHA Library, Charlotte Pawlyn, 54327

PHASE II TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF BENDAMUSTINE, DEXAMETHASONE AND THALIDOMIDE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS AFTER TREATMENT WITH LENALIDOMIDE AND BORTEZOMIB

EHA Library, Michael Mian, 54328

PROGNOSTIC IMPACT OF IMMUNOPHENOTYPIC RESPONSE AND NORMALIZATION OF SERUM FREE LIGHT CHAIN AMONG PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Masafumi Fukaya, 54329

EVALUATION OF VAD PROTOCOL IN MULTIPLE MYELOMA OVER A PERIOD OF 10 YEARS

EHA Library, Belhadri Fatiha, 54330

A SIMPLE METHOD TO DETECT COPY NUMBER-NEUTRAL 6P-LOH IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA USING DUPLEX QUANTITATIVE PCR

EHA Library, Yoshitaka Zaimoku, 54331

EPIGENETIC ALTERATIONS IN FANCONI ANAEMIA: ROLE IN DISEASE PROGRESSION AND THERAPEUTIC POTENTIAL

EHA Library, Hélio Belo, 54332

CHRONIC IDIOPATHIC NEUTROPENIA DOES NOT DISPLAY FREQUENT STAT3 MUTATIONS: IMPLICATIONS FOR DIFFERENTIAL DIAGNOSIS FROM OTHER CLINICAL SYNDROMES WITH T-CELL-MEDIATED SUPPRESSION OF HEMATOPOIESIS

EHA Library, Evangelia Stalika, 54333

PARAMETERS OF CELL IMMUNITY IN PATIENTS WITH APLASTIC ANEMIA AND THEIR RELATION TO PNH-CLONE

EHA Library, Tatyana Glazanova, 54335

INTERIM REPORT OF THE OPTIMA {OBSERVATION OF GPI-ANCHORED PROTEIN DEFICIENT (PNH-TYPE) CELLS IN JAPANESE PATIENTS WITH BONE MARROW FAILURE SYNDROME AND IN THOSE SUSPECTED OF HAVING PNH} STUDY

EHA Library, Chiharu Sugimori, 54338

INCREASED BONE MARROW (BM) PLASMA LEVELS OF SOLUBLE CD30 CORRELATE WITH BM PLASMA LEVELS OF INTERFERON (IFN)-GAMMA, CD4/CD8 T-CELL RATIO AND DISEASE SEVERITY IN APLASTIC ANEMIA

EHA Library, Jizhou Zhang, 54341

EVALUATION OF GENETIC TESTING FOR FANCONI ANAEMIA: FROM SANGER TO NEXT GENERATION SEQUENCE ANALYSIS

EHA Library, Anne Goodeve, 54342

DIAMOND-BLACKFAN ANEMIA IN RUSSIAN FEDERATION

EHA Library, Nataliya S. Smetanina, 54343

TELOMERASE ENZYME ACTIVITY IN EGYPTIAN CHILDREN WITH E ANDBONE MARROW FAILUR RESPONSE TO IMMUNESUPRESSIVE THERAPY

EHA Library, Amal El Beshlawy, 54344

INCREASED INCIDENCE OF TRISOMY 8 IN APLASTIC ANEMIA PATIENTS COMBINED WITH BEHCET'S DISEASE COMPARED TO ACQUIRED APLASTIC ANEMIA: A SINGLE INSTITUTE EXPERIENCE

EHA Library, Soo-Jeong Kim, 54346

PKC412 (MIDOSTAURIN) IS SAFE AND HIGHLY EFFECTIVE IN SYSTEMIC MASTOCYTOSIS PATIENTS: FOLLOW UP OF A SINGLE-CENTER ITALIAN COMPASSIONATE USE

EHA Library, Cristina papayannidis, 54349

DIAGNOSTIC ACCURACY OF SERUM EPO LEVEL AND JAK2V617F ALLELE BURDEN IN POLYCYTHEMIA VERA

EHA Library, Agueda Ancochea, 54350

CALR MUTATIONS IN ESSENTIAL THROMBOCYTHEMIA: INCIDENCE, CLINICAL UTILITY AND MOLECULAR DIAGNOSTIC BY HIGH RESOLUTION MELTING

EHA Library, Teresa Gómez Casares, 54351

POMALIDOMIDE IN MYELOFIBROSIS: LONG TERM FOLLOW UP AND CORRELATION WITH JAK2V617F AND CALR MUTATIONS

EHA Library, Kebede Begna, 54352

YOUNG AGE IS NOT PROTECTIVE AGAINST THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA

EHA Library, Maria Luigia Randi, 54353

A PROGNOSTIC MODEL TO PREDICT THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Danijela Lekovic, 54356

CLINICAL FEATURES OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA DIAGNOSED BETWEEN THE AGES OF 41-59YEARS IN COMPARISON TO PATIENTS DIAGNOSED AT OR BELOW THE AGE OF 40

EHA Library, Grace Kam, 54357

CARDIOVASCULAR EVENTS: RISK FACTORS AND CORRELATIONS WITH THE JAK2V617F ALLELE BURDEN IN PATIENTS WITH PH\'-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS. A MONOCENTRIC STUDY.

EHA Library, Giulia Fontanelli, 54358

BACK TO LIFE -LIVING, TREATING, MANAGING MYELOFIBROSIS: THE BURDEN OF ILLNESS FOR PATIENTS AND THEIR FAMILIES

EHA Library, Maria Giulia Marini, 54359

GENDER DIFFERENCES AND MPN SYMPTOM BURDEN: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG)

EHA Library, Holly L Geyer, 54360

OUTCOME OF PATIENTS AGED OVER 60 WITH CLASSICAL HODGKIN LYMPHOMA TREATED WITH ABVD

EHA Library, Aspasia Stamatoullas, 54361

EVALUATION OF THE PROGNOSTIC ROLE OF TISSUE ASSOCIATED MACROPHAGES (TAM) IN HODGKIN LYMPHOMA AND CORRELATION WITH EARLY FDG-PET ASSESSMENT.

EHA Library, Alberto FABBRI, 54362

ROLE OF BONE MARROW BIOPSY IN HODGKIN LYMPHOMA STAGING IN THE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY ERA.

EHA Library, Stefano Volpetti, 54363

A RANDOMIZED TRIAL OF ROUTINE SURVEILLANCE IMAGING PROCEDURES: ULTRASONOGRAPHY PLUS CHEST RADIOGRAPH VS FDG PET/CT FOR DETECTING RELAPSE IN PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA

EHA Library, Novella Pugliese, 54365

PET-ADAPTED TREATMENT MODIFICATION IN EARLY STAGE HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Marie Therese Sickinger, 54366

PROGNOSTICATION BY FDG-PET DETECTED BONE MARROW INVOLVEMENT IN HODGKINS LYMPHOMA - A RETROSPECTIVE ANALYSIS.

EHA Library, Hari Menon, 54367

DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HL): PRELIMINARY RESULTS OF A PHASE II, PROSPECTIVE, ONGOING MULTICENTER STUDY BY FONDAZIONE ITALIANA LINFOMI

EHA Library, Rita Mazza, 54368

THE PROGNOSTIC SIGNIFICANCE OF THE ABSOLUTE LYMPHOCYTE TO ABSOLUTE MONOCYTE COUNT RATIO (ALC/AMC) IN HODGKIN LYMPHOMA (HL) UNDER TREATMENT WITH ABVD OR EQUIVALENT REGIMENS WITH OR WITHOUT RADIOTHERAPY

EHA Library, Maria Dimopoulou, 54369